Heparin-induced thrombocytopenia screening: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Heparin-induced thrombocytopenia}} | {{Heparin-induced thrombocytopenia}} | ||
{{CMG}}; | {{CMG}};{{shyam}} | ||
==Overview== | ==Overview== | ||
There are no established screening methods for HIT. | |||
==Screening== | ==Screening== | ||
There are no screening methods for HIT. A diagnostic workup includes assessment of the anti-PF4 IgG optical density. However, this is not a screening tool for HIT. | |||
==Reference== | ==Reference== | ||
Latest revision as of 04:26, 30 July 2017
|
Heparin-induced thrombocytopenia |
|
Differentiating Heparin-induced thrombocytopenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Heparin-induced thrombocytopenia screening On the Web |
|
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia screening |
|
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
|
Risk calculators and risk factors for Heparin-induced thrombocytopenia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Shyam Patel [2]
Overview
There are no established screening methods for HIT.
Screening
There are no screening methods for HIT. A diagnostic workup includes assessment of the anti-PF4 IgG optical density. However, this is not a screening tool for HIT.